ES2185938T3 - Procedimiento citofluorometrico para la deteccion en suero de anticuerpos dirigidos frente a antigenos tumorales. - Google Patents

Procedimiento citofluorometrico para la deteccion en suero de anticuerpos dirigidos frente a antigenos tumorales.

Info

Publication number
ES2185938T3
ES2185938T3 ES97923025T ES97923025T ES2185938T3 ES 2185938 T3 ES2185938 T3 ES 2185938T3 ES 97923025 T ES97923025 T ES 97923025T ES 97923025 T ES97923025 T ES 97923025T ES 2185938 T3 ES2185938 T3 ES 2185938T3
Authority
ES
Spain
Prior art keywords
cytofluorometric
procedure
tumor antigens
antibodies against
against tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97923025T
Other languages
English (en)
Inventor
Gianni Bussolati
Alberto Bartorelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zetesis SpA
Original Assignee
Zetesis SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis SpA filed Critical Zetesis SpA
Application granted granted Critical
Publication of ES2185938T3 publication Critical patent/ES2185938T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE TRATA DE UN PROCEDIMIENTO CITOFLUOROMETRICO PARA DETECTAR LA PRESENCIA DE ANTICUERPOS DIRIGIDOS CONTRA ANTIGENOS TUMORALES, UTILIZANDO CELULAS TUMORALES INACTIVADAS ENTERAS QUE EXPRESAN TALES ANTIGENOS TUMORALES.
ES97923025T 1996-05-10 1997-05-08 Procedimiento citofluorometrico para la deteccion en suero de anticuerpos dirigidos frente a antigenos tumorales. Expired - Lifetime ES2185938T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000943A IT1283634B1 (it) 1996-05-10 1996-05-10 Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali

Publications (1)

Publication Number Publication Date
ES2185938T3 true ES2185938T3 (es) 2003-05-01

Family

ID=11374241

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97923025T Expired - Lifetime ES2185938T3 (es) 1996-05-10 1997-05-08 Procedimiento citofluorometrico para la deteccion en suero de anticuerpos dirigidos frente a antigenos tumorales.

Country Status (10)

Country Link
EP (1) EP0901632B1 (es)
JP (1) JP2000510589A (es)
AT (1) ATE227027T1 (es)
AU (1) AU2894597A (es)
DE (1) DE69716728T2 (es)
DK (1) DK0901632T3 (es)
ES (1) ES2185938T3 (es)
IT (1) IT1283634B1 (es)
PT (1) PT901632E (es)
WO (1) WO1997043648A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623620A (en) * 1983-08-02 1986-11-18 Stichting Vrienden Van De Stichting Dr. Karl Landsteiner Enucleated granulocytes, their preparation and use
CA2075928A1 (en) * 1991-01-11 1992-07-12 Roger W. Hackett Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione

Also Published As

Publication number Publication date
ITMI960943A1 (it) 1997-11-10
AU2894597A (en) 1997-12-05
EP0901632A1 (en) 1999-03-17
IT1283634B1 (it) 1998-04-23
DE69716728T2 (de) 2003-03-20
DE69716728D1 (de) 2002-12-05
JP2000510589A (ja) 2000-08-15
ATE227027T1 (de) 2002-11-15
EP0901632B1 (en) 2002-10-30
PT901632E (pt) 2003-02-28
ITMI960943A0 (es) 1996-05-10
WO1997043648A1 (en) 1997-11-20
DK0901632T3 (da) 2003-03-03

Similar Documents

Publication Publication Date Title
NO20001238D0 (no) Monoklonalt antistoff som induserer apoptose
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
DK242781A (da) Assaymetode og reagens dertil
FI842992A0 (fi) Immunologiskt definitionsfoerfarande.
ES2074062T3 (es) Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda.
ES2131038T3 (es) Procedimiento inmunologico para detectar anticuerpos dirigidos contra la transglutaminasa tisular (ttg), utilizacion de la ttg para fines de diagnostico y de control de terapia y agente farmaceutico oral que contiene la ttg.
EA200000449A1 (ru) Модифицированные витамины к-зависимые полипептиды
EP0956304A4 (en) SPECIFIC ANTIBODIES FOR DENDRITIC CELLS
ES554795A0 (es) Un metodo de ensayo mejorado para la determinacion de analitos bioligicos tales como haptenos, antigenos ,receptores , farmacos y similares.
ES2138102T3 (es) Procedimiento para la deteccion de antigeno urinario asociado a tumores.
DE69934426D1 (de) KREBSIMMUNTHERAPIE UND KREBSDIAGNOSE UNTER VERWENDUNG UNIVERSELLER TUMORASSOZIIERTER ANTIGENE EINSCHLIESSLICH hTERT
ES2167590T3 (es) Metodo para diagnosticar enfermedades autoinmunes.
SE8402703D0 (sv) Immunological methods for the determination of metastatic cell activity
SE9703780D0 (sv) Capillary based immunoassay
ES2185938T3 (es) Procedimiento citofluorometrico para la deteccion en suero de anticuerpos dirigidos frente a antigenos tumorales.
NO883140D0 (no) Fremgangsmaate ved leting etter naturressurser.
GB1458282A (en) Xerox corporation detecting a diffusing medium
ES483352A0 (es) Procedimiento para la deteccion de anticuerpos antimitocon- driales o antinucleares
DK0991945T4 (da) Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum
PT744027E (pt) Utilizacao de metodos para identificar oligopeptidos de sinal hidrofilicos
BR0208021A (pt) Genes de antìgeno ii de carcinoma de células escamosas rearranjados
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE260115T1 (de) Reduzierte fett-absorption durch anti-lipase antikörper
ATE420184T1 (de) Fasciola hepatica impfstoffe
FI881122A (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista